Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: F
Results 171 - 180 of 245 shown below

  • focus groups

    E P Wright, M A Kiely, P Lynch, A Cull and P J Selby

    Social problems in oncology

    doi:10.1038/sj.bjc.6600642

  • focused ultrasound surgery

    F Wu, Z-B Wang, Y-De Cao, W-Z Chen, J Bai, J-Z Zou and H Zhu

    A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer

    doi:10.1038/sj.bjc.6601411

  • folate

    M Linnebank, S Schmidt, H Kolsch, A Linnebank, R Heun, I G H Schmidt-Wolf, A Glasmacher, K Fliessbach, T Klockgether, U Schlegel and H Pels

    The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma

    advance online publication, 2004-04-06 00:00:00.000;

    doi:10.1038/sj.bjc.6601777

  • M Pufulete, R Al-Ghnaniem, J A Rennie, P Appleby, N Harris, S Gout, P W Emery and T A Sanders

    Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer

    advance online publication, 2005-02-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602439

  • M M I Hussien, H McNulty, N Armstrong, P G Johnston, R A J Spence and Y Barnett

    Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients

    advance online publication, 2005-04-05 00:00:00.000;

    doi:10.1038/sj.bjc.6602530

  • W R Bruce, M Cirocco, A Giacca, Y-I Kim, N Marcon and S Minkin

    A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation

    advance online publication, 2005-08-30 00:00:00.000;

    doi:10.1038/sj.bjc.6602770

  • R Sharma, L Rivory, P Beale, S Ong, L Horvath and S J Clarke

    A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer

    advance online publication, 2006-03-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603049

  • R A Hubner, J-F Liu, G S Sellick, R F A Logan, R S Houlston and K R Muir

    Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma

    advance online publication, 2007-10-30 00:00:00.000;

    doi:10.1038/sj.bjc.6604056

  • R A Hubner and R S Houlston

    Folate and colorectal cancer prevention

    advance online publication, 2008-12-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604823

  • C Lemos, I Kathmann, E Giovannetti, C Calhau, G Jansen and G J Peters

    Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib

    advance online publication, 2009-03-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604980

  • I Kato, A M Dnistrian, M Schwartz, P Toniolo, K Koenig, R E Shore, A Akhmedkhanov and A Zeleniuch-Jacquotte

    Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study

    doi:10.1038/sj.bjc.6690305

  • M P A Zeegers, R A Goldbohm and P A van den Brandt

    Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study

    doi:10.1054/bjoc.2001.1968

  • folate analogue

    D Bissett, H L McLeod, B Sheedy, M Collier, Y Pithavala, L Paradiso, M Pitsiladis and J Cassidy

    Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034

    doi:10.1054/bjoc.2000.1601

  • folate-independent

    L A Skelton, M G Ormerod, J Titley, R Kimbell, L A Brunton and A L Jackman

    A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus

    doi:10.1038/sj.bjc.6690270

  • folic acid deficiency

    S J Duthie, G Grant and S Narayanan

    Increased uracil misincorporation in lymphocytes from folate-deficient rats

    doi:10.1054/bjoc.2000.1481

  • folinic acid

    P Correale, S Messinese, S Marsili, F Ceciarini, D Pozzessere, R Petrioli, M Sabatino, D Cerretani, M Pellegrini, T Di Palma, A Neri, A Calvanese, E Pinto, G Giorgi and G Francini

    A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid

    doi:10.1038/sj.bjc.6601045

  • Y Chao, K H Yeh, C J Chang, L T Chen, T Y Chao, M F Wu, C S Chang, J Y Chang, C Y Chung, W Y Kao, R K Hsieh and A L Cheng

    Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

    advance online publication, 2004-06-29 00:00:00.000;

    doi:10.1038/sj.bjc.6601985

  • J P Braybrooke, D J Propper, K J O'Byrne, M I Koukourakis, A V Patterson, S Houlbrook, S D Love, S Varcoe, M Taylor, T S Ganesan, D C Talbot and A L Harris

    Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

    doi:10.1054/bjoc.2000.1230

  • folinic acid; adjuvant therapy

    A Saini, A R Norman, D Cunningham, I Chau, M Hill, D Tait, T Hickish, T Iveson, F Lofts, D Jodrell, P J Ross and J Oates

    Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

    doi:10.1038/sj.bjc.6600995

  • follicle stimulating hormone (FSH)

    S Davies, C M R Bax, E Chatzaki, T Chard and R K Iles

    Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)

    doi:10.1054/bjoc.2000.1507

  • follicular adenoma

    T Takano, A Miyauchi, H Yoshida, K Kuma and N Amino

    High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas

    advance online publication, 2004-03-09 00:00:00.000;

    doi:10.1038/sj.bjc.6601702